ALARIS Medical Systems Elects Jacqueline Kosecoff to Board Of Directors.Business Editors/Health/Medical Writers SAN DIEGO--(BUSINESS WIRE)--Dec. 12, 2003 ALARIS Medical Systems Inc. (NYSE NYSE See: New York Stock Exchange : AMI) today announced that Jacqueline Kosecoff, Ph.D., has been elected to serve as a member of its Board of Directors. Dr. Kosecoff is executive vice president, Pharmaceutical Services at PacifiCare Health Systems PacifiCare Health Systems (former NYSE: PHS) was a Fortune 500 healthcare company based in Cypress, California. It was acquired by UnitedHealth Group (NYSE: UNH) in late 2005, which continues to market health plans under the PacifiCare name. Inc. (NYSE: PHS (Personal Handyphone System) A TDMA-based cellular phone system introduced in Japan in mid-1995. Operating in the 1880-1930 MHz band, PHS uses microcells that cover an area only 100 to 500 meters in diameter, resulting in lower equipment costs but requiring more base ), one of the nation's largest consumer health organizations. Prior to joining PacifiCare, Dr. Kosecoff was founder, president and chief operating officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. of Protocare (now Constella Health Strategies and Radiant Research), a firm whose lines of business included the clinical development of drugs, devices, biopharmaceutical and nutritional products and health services consulting. Dr. Kosecoff was co-founder and co-CEO of Value Health Sciences (VHS), a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of Value Health Inc. (NYSE: VHI). VHS was the first company to combine medical sciences and information technology to reengineer the utilization review and approval process, and sent on to introduce sophisticated systems that brought health services data into management's use. Dr. Kosecoff is a recognized expert in the areas of clinical and health services research Health services research is the multidisciplinary field of scientific investigation that studies how social factors, financing systems, organizational structures and processes, health technologies, and personal behaviors affect access to health care, the quality and cost of health care, , quality of care and technology assessment, disease management and organization of the health care delivery system. She served as Professor of Medicine and Public Health at the University of California, Los Angeles UCLA comprises the College of Letters and Science (the primary undergraduate college), seven professional schools, and five professional Health Science schools. Since 2001, UCLA has enrolled over 33,000 total students, and that number is steadily rising. , where she still holds a Research Professorship. She has published extensively in such journals as the New England Journal of Medicine The New England Journal of Medicine (New Engl J Med or NEJM) is an English-language peer-reviewed medical journal published by the Massachusetts Medical Society. It is one of the most popular and widely-read peer-reviewed general medical journals in the world. , Journal of the American Medical Association JAMA: The Journal of the American Medical Association is an international peer-reviewed general medical journal, published 48 times per year by the American Medical Association. JAMA is the most widely circulated medical journal in the world. and the Annals of Internal Medicine Annals of Internal Medicine (Ann Intern Med) is an academic medical journal published by the American College of Physicians (ACP). It publishes research articles and reviews in the area of internal medicine. Its current editor is Harold C. Sox. . "Jackie is an excellent addition to our Board," said David L. Schlotterbeck, president and chief executive officer. "Her skills and experience with both the medical community and the hospital and healthcare systems' information technology environments will bring valuable perspectives to our Board as we continue our commitment to deliver practical solutions for intravenous medication safety at the critical point of care." Dr. Kosecoff has also served as a consultant to the World Health Organization's Global Quality Assessment Programs, on the Institute of Medicine's Board of Health Care Services and the RAND Graduate School's Board of Governors. Currently, Dr. Kosecoff sits on the board of directors for the City of Hope, Pharmaceutical Care Management Association (PCMA) and STERIS Corp. (NYSE: STE). Dr. Kosecoff holds a BA from the University of California, Los Angeles, an MS in Applied Mathematics from Brown University, and a doctorate in Research Methods from the University of California, Los Angeles. Her election expands the ALARIS Medical Systems Inc. Board of Directors from six to seven members. About ALARIS Medical Systems Inc. ALARIS Medical Systems Inc. (NYSE: AMI) develops and markets products for the safe delivery of intravenous (IV) medications. The company's IV medication and infusion therapy delivery systems, software applications, needle-free disposables and related monitoring equipment are marketed in the United States and internationally. ALARIS Medical Systems' "smart" pumps, with the proprietary Guardrails(R) Safety Software, help to reduce the risks and costs of medication errors, help to safeguard patients and clinicians and gather and record clinical information for review, analysis and interpretation. The company provides its products, professional and technical support and training services to over 5,000 hospital and health care systems, as well as alternative care sites, in more than 120 countries through its direct sales force and distributors. With headquarters in San Diego, ALARIS Medical Systems employs approximately 2,900 people worldwide. Additional information on ALARIS Medical Systems can be found at http://www.alarismed.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion